Neratinib-based combination therapy in her2-mutant lung adenocarcinomas: Findings from two international phase 2 studies Meeting Abstract
| Authors: | Li, B.; Gandhi, L.; Besse, B.; Jhaveri, K.; Mazières, J.; Boni, V.; Shapiro, G.; Waqar, S.; Viteri, S.; Park, H.; Quinn, D.; Stemmer, S.; Cortot, A.; Burkard, M.; Scaltriti, M.; Won, H.; Lalani, A.; McCulloch, L.; Bebchuk, J.; Xu, F.; Bryce, R.; Meric-Bernstam, F.; Piha-Paul, S.; Solit, D.; Janne, P. |
| Abstract Title: | Neratinib-based combination therapy in her2-mutant lung adenocarcinomas: Findings from two international phase 2 studies |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | lung cancer; neratinib; her2 mutant |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S234 |
| Language: | English |
| ACCESSION: | WOS:000631349600309 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.158 |
| Notes: | Meeting Abstract: FP14.15 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
Altmetric
Citation Impact
Related MSK Work